ADIPOQ and breast cancer: Liu et al. showed that adiponectin treatment induces Wnt inhibitory factor 1 (WIF1) in a time-dependent manner and results in the decrease of cell proliferation, nuclear translocation of β-Catenin, and reduces expression of cyclin-D1 in breast cancer cells [152].